608 related articles for article (PubMed ID: 26388847)
1. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.
Chang YT; Lin CY; Chen YH; Hsueh PR
Front Microbiol; 2015; 6():893. PubMed ID: 26388847
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
3. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
6. A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against
Ismail N; Zam Z; Hassan SA; Rahman ZA
Malays J Med Sci; 2017 Mar; 24(2):21-27. PubMed ID: 28894400
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
10. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.
Downhour NP; Petersen EA; Krueger TS; Tangella KV; Nix DE
Ann Pharmacother; 2002 Jan; 36(1):63-6. PubMed ID: 11816260
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
Penzak SR; Abate BJ
Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of acquired resistance genes in Stenotrophomonas maltophilia].
Song JH; Sung JY; Kwon KC; Park JW; Cho HH; Shin SY; Ko YH; Kim JM; Shin KS; Koo SH
Korean J Lab Med; 2010 Jun; 30(3):295-300. PubMed ID: 20603591
[TBL] [Abstract][Full Text] [Related]
16. The Burden of Bloodstream Infections due to
Cai B; Tillotson G; Benjumea D; Callahan P; Echols R
Open Forum Infect Dis; 2020 May; 7(5):ofaa141. PubMed ID: 32462047
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of integrons, sul1-2 and dfr genes in trimethoprim-sulfametoxazole-resistant Stenotrophomonas maltophilia strains isolated from clinical samples].
Ozkaya E; Aydin F; Bayramoglu G; Buruk CK; Sandalli C
Mikrobiyol Bul; 2014 Apr; 48(2):201-12. PubMed ID: 24819258
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
19. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
Ansari SR; Hanna H; Hachem R; Jiang Y; Rolston K; Raad I
Cancer; 2007 Jun; 109(12):2615-22. PubMed ID: 17487860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
